Skip to main content
. 2014 Sep;196(18):3214–3220. doi: 10.1128/JB.01876-14

FIG 3.

FIG 3

cdsA mutants, pgsA444, and plsC overexpression increase resistance to vancomycin. (A) Partial loss-of-function cdsA mutants suppress the vancomycin sensitivity of other cell envelope mutants. EOPs of strains supplemented with 120 mg/liter vancomycin. (B) Partial loss-of-function cdsA mutants and pgsA444 increase vancomycin resistance in wild-type cells. EOPs of strains supplemented with 200 mg/liter vancomycin. (C) Overproduction of PlsC increases vancomycin resistance in wild-type cells. EOPs of strains supplemented with 200 mg/liter vancomycin and 0.1 mM IPTG.